Endocrinology drugs are used to treat hormonal problems such as hypothyroidism, diabetes and others.
One of the market drivers is increase in prevalence of endocrine hormone-related diseases.
In 2019, the market size of Endocrinology Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Endocrinology Drugs.
This report studies the global market size of Endocrinology Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Endocrinology Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
AbbVie
AstraZeneca
Eli Lilly
Merck
Novo Nordisk
Sanofi
...
Market Segment by Product Type
Diabetes Drugs
Testosterone Replacement Drugs
Human Growth Hormone Drugs
Thyroid Hormone Disorder Drugs
Market Segment by Application
Hospitals
Commercial Laboratories
Ambulatory Care Centres
Other Setting
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Endocrinology Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Endocrinology Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Endocrinology Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
One of the market drivers is increase in prevalence of endocrine hormone-related diseases.
In 2019, the market size of Endocrinology Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Endocrinology Drugs.
This report studies the global market size of Endocrinology Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Endocrinology Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
AbbVie
AstraZeneca
Eli Lilly
Merck
Novo Nordisk
Sanofi
...
Market Segment by Product Type
Diabetes Drugs
Testosterone Replacement Drugs
Human Growth Hormone Drugs
Thyroid Hormone Disorder Drugs
Market Segment by Application
Hospitals
Commercial Laboratories
Ambulatory Care Centres
Other Setting
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Endocrinology Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Endocrinology Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Endocrinology Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Endocrinology Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 Diabetes Drugs
1.3.3 Testosterone Replacement Drugs
1.3.4 Human Growth Hormone Drugs
1.3.5 Thyroid Hormone Disorder Drugs
1.4 Market Segment by Application
1.4.1 Global Endocrinology Drugs Market Share by Application (2019-2025)
1.4.2 Hospitals
1.4.3 Commercial Laboratories
1.4.4 Ambulatory Care Centres
1.4.5 Other Setting
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Endocrinology Drugs Market Size
2.1.1 Global Endocrinology Drugs Revenue 2014-2025
2.1.2 Global Endocrinology Drugs Sales 2014-2025
2.2 Endocrinology Drugs Growth Rate by Regions
2.2.1 Global Endocrinology Drugs Sales by Regions 2014-2019
2.2.2 Global Endocrinology Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Endocrinology Drugs Sales by Manufacturers
3.1.1 Endocrinology Drugs Sales by Manufacturers 2014-2019
3.1.2 Endocrinology Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Endocrinology Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Endocrinology Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Endocrinology Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Endocrinology Drugs Price by Manufacturers
3.4 Key Manufacturers Endocrinology Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Endocrinology Drugs Market
3.6 Key Manufacturers Endocrinology Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Diabetes Drugs Sales and Revenue (2014-2019)
4.1.2 Testosterone Replacement Drugs Sales and Revenue (2014-2019)
4.1.3 Human Growth Hormone Drugs Sales and Revenue (2014-2019)
4.1.4 Thyroid Hormone Disorder Drugs Sales and Revenue (2014-2019)
4.2 Global Endocrinology Drugs Sales Market Share by Type
4.3 Global Endocrinology Drugs Revenue Market Share by Type
4.4 Endocrinology Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Endocrinology Drugs Sales by Application
6 United States
6.1 United States Endocrinology Drugs Breakdown Data by Company
6.2 United States Endocrinology Drugs Breakdown Data by Type
6.3 United States Endocrinology Drugs Breakdown Data by Application
7 European Union
7.1 European Union Endocrinology Drugs Breakdown Data by Company
7.2 European Union Endocrinology Drugs Breakdown Data by Type
7.3 European Union Endocrinology Drugs Breakdown Data by Application
8 China
8.1 China Endocrinology Drugs Breakdown Data by Company
8.2 China Endocrinology Drugs Breakdown Data by Type
8.3 China Endocrinology Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Endocrinology Drugs Breakdown Data by Company
9.2 Rest of World Endocrinology Drugs Breakdown Data by Type
9.3 Rest of World Endocrinology Drugs Breakdown Data by Application
9.4 Rest of World Endocrinology Drugs Breakdown Data by Countries
9.4.1 Rest of World Endocrinology Drugs Sales by Countries
9.4.2 Rest of World Endocrinology Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 AbbVie
10.1.1 AbbVie Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Endocrinology Drugs
10.1.4 Endocrinology Drugs Product Introduction
10.1.5 AbbVie Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Endocrinology Drugs
10.2.4 Endocrinology Drugs Product Introduction
10.2.5 AstraZeneca Recent Development
10.3 Eli Lilly
10.3.1 Eli Lilly Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Endocrinology Drugs
10.3.4 Endocrinology Drugs Product Introduction
10.3.5 Eli Lilly Recent Development
10.4 Merck
10.4.1 Merck Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Endocrinology Drugs
10.4.4 Endocrinology Drugs Product Introduction
10.4.5 Merck Recent Development
10.5 Novo Nordisk
10.5.1 Novo Nordisk Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Endocrinology Drugs
10.5.4 Endocrinology Drugs Product Introduction
10.5.5 Novo Nordisk Recent Development
10.6 Sanofi
10.6.1 Sanofi Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Endocrinology Drugs
10.6.4 Endocrinology Drugs Product Introduction
10.6.5 Sanofi Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Endocrinology Drugs Sales Channels
11.2.2 Endocrinology Drugs Distributors
11.3 Endocrinology Drugs Customers
12 Market Forecast
12.1 Global Endocrinology Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Endocrinology Drugs Sales Forecast by Type
12.3 Global Endocrinology Drugs Sales Forecast by Application
12.4 Endocrinology Drugs Forecast by Regions
12.4.1 Global Endocrinology Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Endocrinology Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Endocrinology Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 Diabetes Drugs
1.3.3 Testosterone Replacement Drugs
1.3.4 Human Growth Hormone Drugs
1.3.5 Thyroid Hormone Disorder Drugs
1.4 Market Segment by Application
1.4.1 Global Endocrinology Drugs Market Share by Application (2019-2025)
1.4.2 Hospitals
1.4.3 Commercial Laboratories
1.4.4 Ambulatory Care Centres
1.4.5 Other Setting
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Endocrinology Drugs Market Size
2.1.1 Global Endocrinology Drugs Revenue 2014-2025
2.1.2 Global Endocrinology Drugs Sales 2014-2025
2.2 Endocrinology Drugs Growth Rate by Regions
2.2.1 Global Endocrinology Drugs Sales by Regions 2014-2019
2.2.2 Global Endocrinology Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Endocrinology Drugs Sales by Manufacturers
3.1.1 Endocrinology Drugs Sales by Manufacturers 2014-2019
3.1.2 Endocrinology Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Endocrinology Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Endocrinology Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Endocrinology Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Endocrinology Drugs Price by Manufacturers
3.4 Key Manufacturers Endocrinology Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Endocrinology Drugs Market
3.6 Key Manufacturers Endocrinology Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Diabetes Drugs Sales and Revenue (2014-2019)
4.1.2 Testosterone Replacement Drugs Sales and Revenue (2014-2019)
4.1.3 Human Growth Hormone Drugs Sales and Revenue (2014-2019)
4.1.4 Thyroid Hormone Disorder Drugs Sales and Revenue (2014-2019)
4.2 Global Endocrinology Drugs Sales Market Share by Type
4.3 Global Endocrinology Drugs Revenue Market Share by Type
4.4 Endocrinology Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Endocrinology Drugs Sales by Application
6 United States
6.1 United States Endocrinology Drugs Breakdown Data by Company
6.2 United States Endocrinology Drugs Breakdown Data by Type
6.3 United States Endocrinology Drugs Breakdown Data by Application
7 European Union
7.1 European Union Endocrinology Drugs Breakdown Data by Company
7.2 European Union Endocrinology Drugs Breakdown Data by Type
7.3 European Union Endocrinology Drugs Breakdown Data by Application
8 China
8.1 China Endocrinology Drugs Breakdown Data by Company
8.2 China Endocrinology Drugs Breakdown Data by Type
8.3 China Endocrinology Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Endocrinology Drugs Breakdown Data by Company
9.2 Rest of World Endocrinology Drugs Breakdown Data by Type
9.3 Rest of World Endocrinology Drugs Breakdown Data by Application
9.4 Rest of World Endocrinology Drugs Breakdown Data by Countries
9.4.1 Rest of World Endocrinology Drugs Sales by Countries
9.4.2 Rest of World Endocrinology Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 AbbVie
10.1.1 AbbVie Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Endocrinology Drugs
10.1.4 Endocrinology Drugs Product Introduction
10.1.5 AbbVie Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Endocrinology Drugs
10.2.4 Endocrinology Drugs Product Introduction
10.2.5 AstraZeneca Recent Development
10.3 Eli Lilly
10.3.1 Eli Lilly Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Endocrinology Drugs
10.3.4 Endocrinology Drugs Product Introduction
10.3.5 Eli Lilly Recent Development
10.4 Merck
10.4.1 Merck Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Endocrinology Drugs
10.4.4 Endocrinology Drugs Product Introduction
10.4.5 Merck Recent Development
10.5 Novo Nordisk
10.5.1 Novo Nordisk Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Endocrinology Drugs
10.5.4 Endocrinology Drugs Product Introduction
10.5.5 Novo Nordisk Recent Development
10.6 Sanofi
10.6.1 Sanofi Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Endocrinology Drugs
10.6.4 Endocrinology Drugs Product Introduction
10.6.5 Sanofi Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Endocrinology Drugs Sales Channels
11.2.2 Endocrinology Drugs Distributors
11.3 Endocrinology Drugs Customers
12 Market Forecast
12.1 Global Endocrinology Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Endocrinology Drugs Sales Forecast by Type
12.3 Global Endocrinology Drugs Sales Forecast by Application
12.4 Endocrinology Drugs Forecast by Regions
12.4.1 Global Endocrinology Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Endocrinology Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
